Works matching IS 1756994X AND DT 2014 AND VI 6 AND IP 12

Results: 4

Transcriptome wide signatures of tumor stage in KIRC: connecting CNV, methylation and transcription factor activity.
Published in:
Genome Medicine, 2014, v. 6, n. 12, p. 1, doi. 10.1186/s13073-014-0117-z
By:
- Qi Liu;
- Pei-Fang Su;
- Shilin Zhao;
- Yu Shyr
Publication type:
Article
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.
Published in:
Genome Medicine, 2014, v. 6, n. 12, p. 1, doi. 10.1186/s13073-014-0116-0
By:
- Guilhamon, Paul;
- Butcher, Lee M.;
- Presneau, Nadege;
- Wilson, Gareth A.;
- Feber, Andrew;
- Paul, Dirk S.;
- Schütte, Moritz;
- Haybaeck, Johannes;
- Keilholz, Ulrich;
- Hoffman, Jens;
- Ross, Mark T.;
- Flanagan, Adrienne M.;
- Beck, Stephan
Publication type:
Article
Complex host genetics influence the microbiome in inflammatory bowel disease.
Published in:
Genome Medicine, 2014, v. 6, n. 12, p. 1, doi. 10.1186/s13073-014-0107-1
By:
- Knights, Dan;
- Silverberg, Mark S.;
- Weersma, Rinse K.;
- Gevers, Dirk;
- Dijkstra, Gerard;
- Hailiang Huang;
- Tyler, Andrea D.;
- van Sommeren, Suzanne;
- Imhann, Floris;
- Stempak, Joanne M.;
- Hu Huang;
- Vangay, Pajau;
- Al-Ghalith, Gabriel A.;
- Russell, Caitlin;
- Sauk, Jenny;
- Knight, Jo;
- Daly, Mark J.;
- Huttenhower, Curtis;
- Xavier, Ramnik J.
Publication type:
Article
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
Published in:
Genome Medicine, 2014, v. 6, n. 12, p. 1, doi. 10.1186/s13073-014-0105-3
By:
- Haider, Syed;
- Jun Wang;
- Nagano, Ai;
- Desai, Ami;
- Arumugam, Prabhu;
- Dumartin, Laurent;
- Fitzgibbon, Jude;
- Hagemann, Thorsten;
- Marshall, John F.;
- Kocher, Hemant M.;
- Crnogorac-Jurcevic, Tatjana;
- Scarpa, Aldo;
- Lemoine, Nicholas R.;
- Chelala, Claude
Publication type:
Article

Works matching IS 1756994X AND DT 2014 AND VI 6 AND IP 12

Transcriptome wide signatures of tumor stage in KIRC: connecting CNV, methylation and transcription factor activity.

Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.

Complex host genetics influence the microbiome in inflammatory bowel disease.

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.